Someone loses 40 pounds on semaglutide, feels lighter and healthier than they have in years, and then notices the drain catching more hair than it used to. Cue the panic, and cue the headlines: “Ozempic is making people go bald.” Here’s the claim that should calm you down and is also true: in almost every case, the drug isn’t poisoning your follicles. The weight loss is. And that distinction changes everything about what to do next.

Related on the Blueprint: Hair-Growth Supplements and How Long Until Hair Loss Treatments Work.

I research hair loss, and the GLP-1 question lands in my inbox constantly now. The fear is understandable and the answer is reassuring, but only if you understand the actual mechanism instead of the scary version. So let’s separate what the trials show from what the internet imagines.

What’s really happening: telogen effluvium

The hair shedding people report on Ozempic, Wegovy, Mounjaro, and the newer agents like retatrutide is, in the large majority of cases, a condition called telogen effluvium. It’s not androgenetic alopecia, it’s not the drug attacking your hair, and it’s not permanent. Telogen effluvium is what happens when a big physiological stress pushes an unusually large share of your follicles out of their growing phase and into their resting (telogen) phase all at once. A couple of months later, those resting hairs shed together, and you see the wave in the shower.^[1]

The classic triggers for telogen effluvium are exactly the things that come with aggressive weight loss: a sudden drop in calorie intake, a shortfall in protein and micronutrients, and the metabolic shock of rapid change. Crash diets and major weight loss have long been documented as causes, well before GLP-1 drugs existed.^[1] The drug is the reason the weight is coming off fast. The fast weight loss is the reason the hair is shedding. The follicle is responding to a deficit, not to a toxin.

The numbers, honestly

Here’s where I have to be careful, because the internet inflates this badly. The large semaglutide weight-loss trial STEP 1 (Wilding et al., 2021) demonstrated dramatic weight loss, a mean of 14.9% of body weight versus 2.4% on placebo, and the most common adverse events were gastrointestinal, not hair loss.^[2] Hair loss in that program was an uncommon, low-frequency event, far down the side-effect list, and that framing matters: this is not something that happens to most people on the drug.

The clearest signal comes from large pharmacovigilance work, which mines real-world adverse-event databases. A 2026 analysis by Lee and Kim of the FDA reporting system found a statistically significant but modest disproportionality signal for alopecia with semaglutide (adjusted reporting odds ratio 1.23), while tirzepatide did not show the same signal.^[3] A separate multi-database study by Nakhla and colleagues (2024) found that GLP-1 drugs were reported with hair loss more than several other diabetes medications, yet still did not cross the threshold for a confirmed positive safety signal.^[4] Read that carefully. There’s a real, small effect, and it’s nowhere near the epidemic the headlines suggest.

Why “it’s the weight loss, not the drug” is the whole story

Think of your follicles as a factory running on a steady supply line of calories, protein, iron, and zinc. When you slash intake and drop weight fast, the factory triages. Hair is biologically optional, so the body throttles it first to protect the essentials. The follicles don’t die. They go on furlough. A few months later you see the furloughed batch fall out together, which feels alarming but is actually the predictable echo of a deficit you created weeks earlier.

That’s why people who lose weight extremely fast on a high dose, or who barely eat because the nausea kills their appetite, tend to report more shedding than people who titrate slowly and eat well. It’s also why the same telogen effluvium shows up after crash diets, bariatric surgery, childbirth, and high fevers.^[1] Same mechanism, different trigger. The drug is just an unusually effective way to create the trigger.

How to mitigate it

Because the cause is a deficit, the fix is to close the deficit while you lose weight. Here’s what I’d focus on.

1. Protect your protein

Hair is mostly protein, and rapid weight loss on a suppressed appetite makes it dangerously easy to under-eat protein for weeks. Prioritize it at every meal. This is the lever with the most leverage, because protein shortfall is one of the most common drivers of nutritional telogen effluvium.

2. Check your ferritin and iron

Low iron stores are a well-documented contributor to hair shedding, and they’re easy to miss when you’re eating less overall.^[5] A simple ferritin test tells you whether your stores are running low. If they are, that’s a fixable, specific cause rather than a mystery. Iron, thyroid markers, and ferritin are standard things to check in any diffuse hair loss.^[6]

3. Titrate slower

The single most underrated move. Slower dose escalation usually means slower, steadier weight loss, less appetite crushing, and a gentler shock to the system. The hair shedding tends to track the pace of the loss, so easing the pace eases the shedding. This is a conversation worth having with your prescriber rather than white-knuckling the fastest titration schedule.

My bottom line

Do GLP-1 drugs cause hair loss? Indirectly, in a minority of people, and almost always through telogen effluvium driven by rapid weight loss and the nutrient deficit that rides along with it, not through any direct attack on the follicle. The trial data put hair loss low on the side-effect list, and the pharmacovigilance signal is real but modest.^[2][3] Best of all, it’s usually reversible. So if you’re shedding on one of these drugs, don’t reflexively quit a medication that’s improving your health. Feed the follicle, check your iron, slow the climb, and give it time. The hair that went on furlough almost always comes back to work.

The full nutrient-and-routine checklist I’d use is in my free protocol below. More of my hair-science work is at philippeb.pro.